Core Faculty
Kim Lyerly, MD
Contact
Degree
MD, University of California at Los Angeles
Telli ML, Nagata H, Wapnir I, Acharya CR, Zablotsky K, Fox BA, et al. Intratumoral Plasmid IL12 Expands CD8+ T Cells and Induces a CXCR3 Gene Signature in Triple-negative Breast Tumors that Sensitizes Patients to Anti-PD-1 Therapy. Clin Cancer Res. 2021 Feb 16;
Wang J, Osada T, Morse MA, Calzone F, Yan H, Thai D, et al. Targeting the glucagon receptor signaling pathway as a novel strategy to counteract PI3K inhibitor induced hyperglycemia while sustaining tumor PI3K inhibition. Leuk Lymphoma. 2021 Feb 12;1–6.
Crosby EJ, Nagata H, Telli ML, Acharya CR, Wapnir I, Zablotsky K, et al. Intratumoral delivery of tavokinogene telseplasmid (plasmid IL-12) and electroporation induces an immune signature that predicts successful combination in patients. In: Cancer Research. 2021.
